Industry News
For Patients With Immune Destruction Of Platelets, Rituximab Promotes Long-Term Response
May 09, 2012
A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP)... Read More
For Patients With Immune Destruction Of Platelets, Rituximab Promotes Long-Term Response
May 09, 2012
A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP)... Read More
News From The Journal Of Clinical Investigation: May 8, 2012
May 09, 2012
VASCULAR BIOLOGY Genetic variation contributes to high blood pressure High blood pressure, or hypertension, is a pervasive problem that increases risk for a number of diseases including stroke, heart attack, peripheral arterial disease and chronic kidney disease. Many molecular pathways contribute to the development of hypertension, including nitric oxide signaling... Read More
Mammary Glands Affected By BPA In Monkeys
May 09, 2012
A new study finds that fetal exposure to the plastic additive bisphenol A, or BPA, alters mammary gland development in primates. The finding adds to the evidence that the chemical can be causing health problems in humans and bolsters concerns about it contributing to breast cancer... Read More
Brachytherapy Effective In Early Stage Breast Cancer In Milk Ducts
May 08, 2012
A new study reveals that women with early-stage breast cancer in the milk ducts that has not metastasized to healthy surrounding breast tissue (ductal carcinoma in situ [DCIS]) appear to benefit from undergoing breast brachytherapy with a strut-based applicator. The study was presented at the annual meeting of the American Society of Breast Surgeons, held in Phoenix May 2 to May 4... Read More
Younger And At-Risk Men Benefit From PSA Screening To Detect Prostate Cancer
May 08, 2012
Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal)... Read More
In Prostate Cancer, Genetic Abnormalities In Benign Or Malignant Tissues Predict Relapse
May 08, 2012
While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis remains a major challenge... Read More
News From The Annals Of Internal Medicine: May 8, 2012, Online
May 08, 2012
1. Evidence Review: Screening Women for Intimate Partner Violence May Have Benefits, Few Harms Intimate partner violence, or IPV, includes a range of abusive behaviors perpetrated by someone who is in an intimate relationship with the victim... Read More
News From The Annals Of Internal Medicine: May 8, 2012, Online
May 08, 2012
1. Evidence Review: Screening Women for Intimate Partner Violence May Have Benefits, Few Harms Intimate partner violence, or IPV, includes a range of abusive behaviors perpetrated by someone who is in an intimate relationship with the victim... Read More
Multi-Center Study Reveals That Eye Color May Indicate Risk For Serious Skin Conditions
May 08, 2012
Eye color may be an indicator of whether a person is high-risk for certain serious skin conditions. A study, led by the University of Colorado School of Medicine, shows people with blue eyes are less likely to have vitiligo. It then follows, according to scientists, that people with brown eyes may be less likely to have melanoma... Read More
Previous Page Next Page